Hope Elizabeth Qamoos, CNP
Women'S Health · Palo Alto
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Hope Elizabeth Qamoos’s office at (650) 498-6004 to ask if they take your plan before you enroll.
California Medical Board record
Licence G21929 · Delinquent
Licence status: Delinquent · since 1972 · expires 2023-06-30 · State University of N.Y. Upstate Medical Ctr, College of Medicine. Board flags: Arbitration Award.
License renewal fee has not been paid. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 1994-07-14 | Arbitration award | $657,900 · Los angeles superior court - central · C 733327 |
State licence records
1 licence
- Illinois 209007964Advanced Practice Registered Nurse · since 2009 · expires 2014-05-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their 205 Part D prescriptions in 2015.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2016 | 33 | 13 | None | None | $33,683 |
| 2015 | 205 | 41 | 7% (14) | 23% | $298,571 |
| 2014 | 168 | 42 | None | 10% | $21,511 |
| 2013 | 216 | 53 | None | 23% | $208,793 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2015: 5 drugs
| Ibrance | 25 | $254,416 | $10,177 |
| Exemestane | 21 | $4,933 | $235 |
| Anastrozole | 25 | $646 | $26 |
| Letrozole | 22 | $238 | $11 |
| Zolpidem | 12 | $55 | $5 |
2014: 4 drugs
| Anastrozole | 41 | $1,787 | $44 |
| Letrozole | 15 | $498 | $33 |
| Ondansetron | 12 | $140 | $12 |
| Lorazepam | 16 | $69 | $4 |
2013: 7 drugs
| Afinitor | 23 | $185,227 | $8,053 |
| Exemestane | 16 | $4,547 | $284 |
| Anastrozole | 42 | $3,203 | $76 |
| Tamoxifen Citrate | 13 | $397 | $31 |
| Letrozole | 12 | $184 | $15 |
| Dexamethasone | 14 | $85 | $6 |
| Lorazepam | 13 | $79 | $6 |
Money from drug and device companies
$50 in 2025
A payment is not proof that care is biased.
| Blueprint Medicines | Ayvakit | $50 | 1 payment
|
See the published payment
| Blueprint Medicines | Meals · 2025-02-28 | Ayvakit | $50 |
Professional record
- NPI
- 1265764666
- Licence
- CA 21929, IL 209007964California G21929: Delinquent · expires 2023-06-30Illinois 209007964: Not Renewed
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LW0102X (363LW0102X); Federal specialty code 363LX0001X (363LX0001X)
- Mailing address
- 1257 Lakeside Dr, 1227, Sunnyvale, CA, 94085
- NPI first listed
- 2010-02-10
- NPI last updated
- 2013-01-30
This is when the NPI record was last certified, not a medical board exam.